Hydrus Microstent as a Quality of Life Consideration

NCT05955118 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2023-07-21

No results posted yet for this study

Summary

The study aims to identify if Hydrus microstent implantation in patients with open angle glaucoma (OAG) at the time of cataract surgery improves quality of life for patients and explore what quality of life factors motivate patients.

Conditions

Interventions

DEVICE

Hydrus Microstent

Hydrus Microstent placed at the time of cataract surgery

Sponsors & Collaborators

  • InSight Vision Center Medical Group, Inc

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-04-01
Completion
2024-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05955118 on ClinicalTrials.gov